University Medical Center Hamburg-Eppendorf: Prostate cancer treatment in Germany
Martini-Klinik is a specialist prostate cancer clinic within the University Medical Center Hamburg-Eppendorf (UKE). UKE is one of the largest hospitals in northern Germany and has a long tradition of treating international patients, seeking treatment in Germany from UKE’s renowned professors and doctors.
Prostate cancer clinic in Germany
The Martini-Klinik is a state-of-the-art clinic for prostate cancer treatment, which is run under the direction of Professor Dr. Hartwig Huland, Professor Dr. Markus Graefen and Professor Dr. Hans Heinzer. The clinic is one of the leading prostate cancer centres worldwide and in 2010 alone, the doctors at the clinic performed nearly 1,800 prostate removals.
The focus of all efforts is always the patient, who at the Martini-Klinik undergoes customized treatment according to his illness. Together with the specially trained urology nursing team, the internationally renowned experts attend to each patient individually during the treatment of prostate cancer. The active involvement of the patient and his family in this process is of utmost importance.
All treatments are based on the latest scientific findings and research and before they are applied they are carefully checked by the Martini-Klinik surgeons. Several extensive databases and tissue banks allow prostate cancer research that is unparalleled. Pseudonymized disease-related information and blood and tissue samples of more than 25,000 patients are available to the Martini-Klinik for scientific research.
Prostate cancer treatment in Germany
Radical retropubic prostatectomy
The Martini-Klinik offers the traditional surgical removal of the prostate, called radical retropubic prostatectomy, wherein the prostate is removed manually by the surgeon. The complete surgical removal of the prostate is particularly appropriate as a treatment option if the cancer is limited to the prostate, when this procedure offers the greatest chance of recovery. Read more about radical retropubic prostatectomy.
Prostate cancer surgery with the daVinci® system
Prostate removal with the surgical system daVinci® is a modern, minimally invasive surgical technique. The surgeon controls the operation via the daVinci® system and has full command of the system at all times. The daVinci® system is a precise micro-surgical instruments that are as flexible as human hands. Cameras provide the surgeon with three-dimensional, 10x magnified images of the surgical field.
The advantages of daVinci® prostatectomy:
small incisions and small scars
significantly less blood loss
a blood transfusion rate of less than one percent
millimetre precision and stable movement
excellent view of the surgical field
Read more about prostate cancer surgery with the daVinci® system.
Brachytherapy is a thoroughly proven form of internal radiotherapy. There are two different forms: LDR brachytherapy (seed implantation) and HDR brachytherapy (afterloading). Read more about brachytherapy.
Radiotherapy can be an alternative to surgery as the primary treatment of prostate cancer, locally advanced tumour stages after a prostatectomy and recurrences of prostate cancer. Read more about radiotherapy.
Tomotherapy is a procedure using a state-of-the-art radiation device consisting of a linear accelerator and a CT scanner. The radiation device moves around the patient and is controlled by an integrated computer tomograph which allows exact determination of the location of cancerous tumours. Read more about tomotherapy.
Hormone deprivation therapy can stop and control tumour growth over an extended period but cannot cure the tumour. The male sex hormone testosterone has a significant influence on the development of prostate cancer. The effect of this hormone can be blocked by administering tablets of antiandrogens. Read more about drug therapy.
Results of prostate cancer treatment abroad
98 percent of UKE patients whose prostates were removed and whose tumours were detected at an organ-confined stage (pT2 tumours) are still alive ten years after the surgery. Even patients with advanced tumours (pT3 and pT4) exhibit survival rates of 72 to 95 percent. Read more about the results of prostate cancer treatment abroad.
Medical tourism services for prostate cancer treatment abroad
The UKE International Office was founded to optimally support international guests who come with different goals and expectations during the planning and implementation of their stays at the UKE.
From the first inquiry to the departure to the home country, the dedicated employees of the International Office will guide patients in all administrative and organizational matters, paying special attention to personal, cultural, and religion-related needs. All incoming requests are handled in this department. English, Russian, Arabic and Bulgarian speaking case managers assure a smooth process for all guests.